OMEGA INTERFERON FOR THE TREATMENT OF HIV/AIDS, CANCER AND HUMAN AND VETERINARY ASTHMA

摘要

The invention relates to a pharmaceutical composition with a whole immunotherapeutic activity, proven at 89 %, activating both cellular and humoral immunity in human and veterinary medicine, the protocol for use and therapeutic indications thereof. Said pharmaceutical composition, once subcutaneously and intramuscularly injected into well-specified sites of the lymphoid system and ganglionic areas of the sick organism, has a both cellular and humoral, progressive and perennial immunotherapeutic effect. The pharmaceutical formula of our composition is based on lymphocytic omega interferon, associated with vasodilator, antioxidant, anticoagulant and corticosteroid agents. The synergistic action of the cytokines and agents is provided for treatment of: chronic viral diseases, specifically HIV1, HIV2, AIDS and viral hepatitis; intracellular parasitic bacteria diseases: bacterial or trypanosomiasis leishmaniasis, tuberculosis, syphilis, chlamydia and mycoplasma; chronic allergic disorders: asthma; mesodermal and lymphoid cancer processes. Our invention and the mode of application thereof are suitable for treating said diseases both in human and veterinary medicine.